Scott Halperin is a Canadian immunologist, professor of pediatrics, microbiology, and immunology at Dalhousie University, the head of Pediatric Infection Diseases at IWK Health Centre, and the director of the Canadian Centre for Vaccinology.^[1][2][3]

Biography

Halperin received a B.Sc. from Stanford University, and an M.D. from Cornell University. He did his postdoctoral research in pediatric infectious diseases at the University of Virginia and University of Minnesota.^[4]

Career

Halperin's research focuses on pertussis and other vaccine-preventable diseases.^[2] In 2020, the Canadian Centre for Vaccinology at Dalhousie University was approved by Health Canada to begin clinical trial for a potential COVID-19 vaccine, led by Halperin.^[5] Halperin's research also focuses on public health policy in relation to the COVID-19 pandemic.^[6]

Awards

From 2004 to 2009, Halperin held the CIHR/Wyeth Pharmaceuticals clinical research chair in vaccines. He received a certificate of merit from the Canadian Paediatric Society in 2009, as well as the Max Forman Senior Research Prize from the Dalhousie Medical Research Foundation, also in 2009.^[4]

References